BOSTON--(BUSINESS WIRE)--Ronald Trahan Associates Inc. (“RTA”) announced today that its Sept. 12, 2013, broadcast of the complementary webinar—“Equity-Based Crowdfunding for Early-Stage Medtech Companies”—is available for postview.
The hour-long webinar, moderated by Ronald Trahan, APR, President of RTA, includes three parts:
- Part One: “The ABCs of Equity-Based Crowdfunding for Early-Stage Medical Device Companies,” presented by J. Casey McGlynn, Partner, Wilson Sonsini Goodrich & Rosatti (www.wsgr.com);
- Part Two: “How to choose the Right Equity-Based Crowdfunding Platform for Your Medtech Company,” presented by Sara Hanks, CEO, Crowdcheck (www.crowdcheck.com); and,
- Part Three: “How to get your Medtech Crowdfunding Campaign Started,” presented by Michael Norman, President and Co-Founder, Wefunder Equity-Based Crowdfund Investing Platform (www.wefunder.com).
CLICK HERE TO REQUEST POSTVIEW ACCESS
"Crowdfunding is very likely to become a precious funding resource for many could-be-great medical technologies that otherwise would go begging for scarce capital,” said Ronald Trahan.
About Ronald Trahan Associates (“RTA”) Inc.
Since 1992, RTA has been offering public relations (PR) counsel and services to emerging medical technology companies and is therefore uniquely positioned to offer content-building counsel and services related to Crowdfunding campaigns for early-stage medtech companies.